The Hemoglobin A1c Testing Devices by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Hemoglobin A1c Testing Devices Market:
According to The Business Research Company’s Hemoglobin A1c Testing Devices, the hemoglobin a1c testing devices market size has grown rapidly in recent years. It will grow from $1.73 billion in 2023 to $1.93 billion in 2024 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to holistic diabetes management programs, continuous innovation, improvement in healthcare infrastructure, preventive healthcare practices, home healthcare trends.
The hemoglobin a1c testing devices market size is expected to see rapid growth in the next few years. It will grow to $2.94 billion in 2028 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to point-of-care testing expansion, home testing and self-monitoring, focus on preventive healthcare, increasing aging population, healthcare accessibility expansion. Major trends in the forecast period include continuous innovation and cost efficiency, rising diabetes prevalence, shift towards point-of-care testing, technological advancements, home healthcare and self-monitoring.
The rising prevalence of diabetes is expected to propel the growth of the hemoglobin A1c testing devices market. Diabetes is a chronic metabolic disorder that elevates blood glucose levels. Hemoglobin A1c testing is used in providing information on average blood glucose levels in individuals that are used in the diagnosis of type 2 diabetes, pre-diabetes, and diabetes management, which enables the individuals to monitor the disease and help make treatment decisions to prevent complications. For instance, in 2022, Centers for Disease Control and Prevention, a US-based national public health agency, around 37.3 million people were suffering from diabetes which equals 11.3% of the United States population. Additionally, in December 2021, according to the International Diabetes Federation, a Belgium-based global diabetes community, approximately 537 million adults were suffering from diabetes globally, whereas 3 out of 4 adults are in low- and middle-income countries. Therefore, the increased cases of diabetes patients will drive the hemoglobin A1c testing devices market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9077&type=smp
The hemoglobin a1c testing devices market covered in this report is segmented –
1) By Type: Bench Top Device, Handheld Device
2) By Technology: Ion-Exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay, Other Technologies
3) By End Use: Hospitals, Pharmaceuticals, Medical Devices, Laboratory Testing
Product innovations are a key trend in gaining popularity in the hemoglobin A1c testing devices market. Major companies operating in the market are focused on developing innovative products to strengthen their position in the market. For instance, in June 2021, Trivitron Healthcare Pvt. Ltd., an India-based medical device company, introduced NANO H5 and NANO H110, advanced diagnostic solutions for HbA1c based on HPLC technology to provide a result within 130 seconds. NANO H5 and NANO H110 are compact, automated HPLC analyzers that use ion exchange liquid chromatography to quantitatively determine glycated hemoglobin (HbA1c) in a human whole blood sample. NANO H5 and NANO H110 can process samples up to 5 and 110, respectively. NANO H110 offers advanced facilities such as a barcode scanner and cap piercing with a high sample loading capacity, making the device suitable for medium to large laboratories.
The hemoglobin a1c testing devices market report table of contents includes:
1. Executive Summary
2. Hemoglobin A1c Testing Devices Market Characteristics
3. Hemoglobin A1c Testing Devices Market Trends And Strategies
4. Hemoglobin A1c Testing Devices Market - Macro Economic Scenario
5. Global Hemoglobin A1c Testing Devices Market Size and Growth
.
.
.
31. Global Hemoglobin A1c Testing Devices Market Competitive Benchmarking
32. Global Hemoglobin A1c Testing Devices Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Hemoglobin A1c Testing Devices Market
34. Hemoglobin A1c Testing Devices Market Future Outlook and Potential Analysis
35. Appendix
Related Reports
https://topprnews.com/biosurgery-market
https://topprnews.com/biotech-ingredient-market
https://topprnews.com/birch-water-market
https://goodprnews.com/biosurgery-market
https://goodprnews.com/biotech-ingredient-market
https://goodprnews.com/birch-water-market
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Transparency Market Research (TMR) has published a new report titled, ‘Hemoglobin A1c Testing Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.
According to the report, the global Hemoglobin A1c Testing Devices market was valued at US$ 1,676.3 Mn in 2018 and is projected to expand at a CAGR of 10.7% from 2019 to 2027.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=73900OverviewHemoglobin A1c testing devices are used to determine and monitor hemoglobin A1c levels in diabetic patients.
It is also known as glycosylated hemoglobin test, glycohemoglobin test, glycated hemoglobin test, or A1C.In terms of technology, ion-exchange HPLC segment dominated the market owing to the establishment of this technology as gold standard method of determination of HbA1c due to its excellent specificity and reproducibility.
A clinical study by the company indicated that 205 patients with SC and diabetes were analyzed using immunoassay and HPLC instrument.
High prevalence of different types of diabetes and rise in the geriatric population in the region are some of the factors augmenting the market in North America are expected to drive the market in North America.Asia Pacific is likely to be a highly lucrative market for retinal disorders and it is expected to expand at a high CAGR during the forecast periodRequest COVID Analysis on Hemoglobin A1c Testing Devices Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=73900Recent approval of HBA1C tests in year 2018 to Drive MarketA1CNow systems developed by PTS Diagnostics got approved in year 2018which provides accurate A1C results in the office or home comes in a convenient 2-test pack or 4-test pack.Abbott laboratories got its Afinion assay product approved which is the first-ever rapid point-of-care test approved to help diagnose diabetes and assess patients’ risk of developing the diseaseBio-Rad Laboratories, Inc product VARIANT II System got its approval which offers fully automated high-volume hemoglobin A1c and β-thalassemia testing, with Clinical Data Management Software and a LIS interface.Request Customization on Hemoglobin A1c Testing Devices Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=73900Faster adoption and Increase in point-of-care testing to Drive MarketPoint-of-care testing provides results within time limit, offers consumer convenience, reduces needle stick injuries, and minimizes contaminationIt has also led to development of the smaller devices, portable, and minimally invasive product.
ADA considers HPLC as the gold standard method for the determination of HbA1c.However, cost of HbA1c treatment using HPLC method compared to other techniques is high, which is likely to induce patients to adopt other techniques.Point-of-care settings to be Highly Lucrative SegmentIn terms of end-user, the global Hemoglobin A1c Testing Devices market has been classified into laboratories, and point-of-care settings.The laboratories segment dominated the Hemoglobin A1c Testing Devices market owing to rise in the number of cases of diabetes type II disorders, enhanced diagnostic care services, and availability of a wide range of services at a single site in commercial laboratories.
According to the recent report by IMARC Group, titled “Hemoglobin Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the market is currently witnessing strong growth.
A hemoglobin (Hgb) test determines the level of hemoglobin or the count of red blood cells (RBC) in the blood.
If the examination reveals low levels of hemoglobin than the standard range, then that means the body is prone to anemia and if it is higher, then it can be a symptom of other disorders.
Subsequently, the doctors prescribe medicines and dietary changes to maintain an optimum level of hemoglobin in the body.As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.Get a sample copy of this Report: https://www.imarcgroup.com/hemoglobin-testing-market/requestsampleGlobal Hemoglobin Testing Market Trends:Fast-paced lifestyles of the working population have led to irregular mealtime and increased the dependence on ready-to-eat food.
Improper diet and stress have led to a rise in the number of chronic diseases, like diabetes and anemia, thereby propelling the demand for hemoglobin testing.
Moreover, the provision of home care testing by several healthcare centers has made the test more convenient for users as they get doorstep services of collecting samples and faster results.
